T2 Biosystems, Inc. 3 SEC Filings

Filed On	Filing
06 Jul 2023	Form 3: Cr Group L.p., 10% owner and 4 others No securities owned
15 Nov 2021	Form 3: Giffin Brett A., Chief Commercial Officer
05 Nov 2021	Form 3: Adams Laura Lee, Director
15 Jan 2021	Form 3: Ahuja Aparna, Chief Medical Officer No securities owned
22 Jun 2020	Form 3: Toft Robin, Director No securities owned
22 Jun 2020	Form 3: Saunders Ninfa, Director No securities owned
22 Jun 2020	Form 3: Bernard Thierry, Director No securities owned
29 Jan 2020	Form 3: Pare Anthony, Chief Commercial Officer Holds 4,577 shares of Common Stock
14 Jan 2020	Form 3: Sperzel John J Iii, Director
14 Mar 2018	Form 3: Barclay Alec, SVP, Operations Holds 890 shares of Common Stock
09 Feb 2018	Form 3: Sprague John M, Chief Financial Officer No securities owned
02 May 2017	Form 3: Deptula-hicks Darlene M, Chief Financial Officer No securities owned
30 Sep 2016	Form 3: Canon U.S.A., Inc., 10% owner and 1 other Holds 6,055,341 shares of Common Stock
22 Sep 2016	Form 3: Liebman Seymour, Director No securities owned
08 Sep 2016	Form 3: Spadoro Joanne, Chief Operations Officer No securities owned
17 May 2016	Form 3: Lynch Shawn, Chief Financial Officer No securities owned
11 Mar 2016	Form 3: Jones Adrian M, Director Holds 4,157,240 shares of Common Stock
22 Feb 2016	Form 3: Dhanda Rahul, SVP of Corporate Development
26 Jan 2016	Form 3: Gibbs Michael Terrence, General Counsel Holds 2,298 shares of Common Stock
09 Nov 2015	Form 3: Harding David, Chief Commercial Officer Holds 1,000 shares of Common Stock

Comments